|Articles|August 31, 2005

Syneture Expands Blunt Tip Needle Portfolio

NORWALK, Conn. -- Syneture, the wound closure business of United States Surgical, today announced the expansion of its ProtectPoint blunt needle surgical needle product portfolio. These products are designed to optimize physician and nurse safety by helping to reduce the risk of needlestick injuries, while still providing the clinical performance that clinicians require.

"Sharp suture needles are the leading cause of needlestick injuries in the operating room," said Janine Jagger, MPH, PhD, professor of internal medicine and director of the International Health Care Worker Safety Center at the University of Virginia Health System. "Our research has shown that suture needles account for 51 percent of all sharps related injuries in the operating room and that their use in suturing muscle and fascia accounted for 59 percent of all suture needle related injuries. (1) The use of blunt tip suture needles for this application alone can prevent more sharps injuries in the OR than any other safety measure, and at the same time reduce patients' risk of exposure to the blood of injured personnel."

The ProtectPoint product line now includes an expanded line of blunt taper needles, specifically designed to reduce tissue penetration force in tougher tissue like muscle and fascia, while still offering superior glove penetration protection. OSHA estimates that the majority of needlestick injuries that occur can be prevented by using safer technologies such as blunt point needles. Needlestick injuries are a potential source for the spread of infectious diseases.

In addition to its expanded line of blunt taper needles, Syneture has also upgraded its blunt point needles with NuCoat coating technology which provides more consistent penetration pass after pass. The ProtectPoint needles, designed for softer tissues, are available with a wide variety of absorbable and nonabsorbable surgical suture materials.

Reference: AORN J. May 1998.

Source: U.S. Surgical


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.